Ocular and Adnexal Lymphoma Second Edition 2023
download
Editors:
Vishal R. Raval • Prithvi Mruthyunjaya Arun D. Singh
Pages: 108
- Language: English
- Format: PDF
- Size : 7.64 MB
- Contents
- . Primary Central Nervous System Lymphoma: Terminology and Outcome Measures
- 1 Arun D. Singh and Vishal R. Rava
. Epidemiological Aspects of Intraocular Lymphoma
M. Sanjana, Anasua Ganguly Kapoor, and Vishal R. Raval
. Ocular and Adnexal Lymphoma: Pathogenesis
and Pathology .
Sarah L. Ondrejka
. Mutational Profile of Ocular Lymphoma
Christopher Seungkyu Lee
. Ocular Adnexal Lymphoma: Clinical Presentation
and Imaging Studies
Kavya Madhuri Bejjanki and Swathi Kaliki
. Intraocular Lymphoma: Clinical Presentation
and Imaging Studies
Kedarisetti Kiran Chandra and Vishal R. Raval
. Intraocular Lymphoma: Biopsy Techniques
Heiferman,
and Prithvi Mruthyunjaya
. Vitreoretinal Lymphoma: Intraocular Therapy
Jacob Pe’er and Shahar Frenkel
. Ocular and Adnexal Lymphoma: Radiation Indications
and Techniques
David Buchberger and Sheen Cherian
. Ocular Adnexal Lymphoma: Systemic Therapy
and Clinical Trials
Allison Winter, Mary Aronow, Arun D. Singh, and Brian Hill
. Primary Central Nervous System Lymphoma:
Neuro-Oncologic Approach
David M. Peereboom
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Preface
Ocular and adnexal lymphomas are rare and diverse; hence their diagnosis
and treatment usually require special expertise. Increasingly, the care of such
a patient is provided by a multidisciplinary team comprising ocular oncologists, general oncologists, pathologists, radiation oncologists, and other specialists. The feld of lymphoma is advancing rapidly because of accelerating
progress in tumor biology, pharmacology, and the advent of targeted therapies. For all these reasons, we felt that there was scope for a new edition of
the monograph regarding ocular and adnexal lymphoma.
To harmonize the terminology across this monograph the editors have
taken the liberty of labeling vitreo-retinal lymphoma as PCNSL-O as the preferred term to emphasize that it is an ocular variant or subset of primary CNS
lymphoma (PCNSL). Those with concurrent CNS and ocular disease may be
labeled as PCNSL-CNS/O in contrast to patients with CNS only involvement
(PCNSL-CNS) at presentation. This monograph, a conjoint effort of ocular
oncologists, general oncologists, and pathologists, comprises 11 chapters
covering molecular pathology, clinical features, and treatment. It is our sincere hope that this monograph will provide a useful resource for providing
appropriate care to our patients.
This, my frst book, would not have taken shape without the guidance of my
mentor, Dr. Arun D Singh, Director of Ophthalmic Oncology, Cole Eye
Institute, Cleveland Clinic, Ohio, USA. My deep and sincere gratitude to Dr.
Singh for the opportunity, and for the privilege and honor to have worked and
studied under him.
I must thank the Hyderabad Eye Research Institute, Hyderabad, for their
support and contribution throughout my research career.
I am also grateful to my parents for their love, prayers, care, and their
many sacrifces to support my education and career. I can always count on my
wife, Shaily, and my daughters, Drishti and Deeti, for their love, understanding, faith, and steady support throughout my research career (Vishal).
To my parents who educated me beyond their means, my wife,
Annapurna, and my children, Nakul and Rahul, who make all my efforts
worthwhile (Arun Singh).
For all I have learned from the pearls of my mentors and the journey of
my patients. Grateful to my late father who taught me the value of helping
those in need (Prithivi).
